Revolution Medici…
USUSDRevolution Medicines, Inc. (US:RVMD) — Biotechnology: Biological Products (No Diagnostic Substances). Numero di borse in cui sono quotate le azioni della società: 1. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.
Informazioni sull'azienda
- Sito web
- revmed.com
- Relazioni con gli investitori
- revmed.com/investors/
- Settore
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Sede centrale
- REDWOOD CITY, United States
- Amministratore delegato
- Dr. Mark A. Goldsmith M.D., Ph.D.
- Dipendenti
- 883
- Fondata
- 2014
- Azioni in circolazione
- 214.34 Mln al 2026-07-31
- Flottante
- 184.5 Mln
- Capitalizzazione di mercato
- 43.24 Mld USD
- Insider
- 1.85%
- Investitori istituzionali
- 101.01%
- Settore (SIC)
- Biological Products, (No Diagnostic Substances)
- ISIN
- US76155X1000
- LEI
- 549300JU3X0LBCQ65892
Descrizione
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Borse e ticker
| Borsa | Ticker | Valuta | Prezzo | Tipo |
|---|---|---|---|---|
| US USA Stocks | RVMD | USD | 200.87 +0.50% | azioni ordinarie |
Dividendi
Nessun pagamento di dividendi trovato (controllato 08.10.2026). Probabilmente la società non distribuisce dividendi.
Notizie di questa settimana
Ancora nessuna notizia dal sito della società.
Principali azionisti
| Detentore | Quota | Azioni | Data del rapporto |
|---|---|---|---|
| Blackrock Inc. | 6.39% | 13.7 Mln | 2026-06-30 |
| Farallon Capital Managem… | 6.32% | 13.55 Mln | 2026-06-30 |
| FMR, LLC | 5.69% | 12.2 Mln | 2026-06-30 |
| Baker Bros. Advisors, LP | 5.34% | 11.44 Mln | 2026-06-30 |
| Jupiter Topco LLC | 5.01% | 10.74 Mln | 2026-06-30 |
| Darwin Global Management… | 4.96% | 10.63 Mln | 2026-06-30 |
| Vanguard Capital Managem… | 4.24% | 9.09 Mln | 2026-06-30 |
| Vanguard Portfolio Manag… | 3.87% | 8.29 Mln | 2026-06-30 |
| Nextech Invest, Ltd. | 3.55% | 7.6 Mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.99% | 6.41 Mln | 2026-06-30 |
| Paradigm Biocapital Advi… | 2.97% | 6.36 Mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.16% | 4.63 Mln | 2026-06-30 |
| Growth Fund of America | 1.38% | 2.96 Mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.25% | 2.67 Mln | 2026-06-30 |
| Fidelity Mt. Vernon Stre… | 1.15% | 2.47 Mln | 2026-07-31 |
| BORISY ALEXIS (Director) | ≈1.09% | 2.34 Mln | 2026-06-18 |
| VANGUARD INDEX FUNDS-Van… | 1.07% | 2.29 Mln | 2026-06-30 |
| VANGUARD SPECIALIZED FUN… | 0.86% | 1.84 Mln | 2026-04-30 |
| iShares Trust-iShares Bi… | 0.65% | 1.39 Mln | 2026-07-31 |
| JPMorgan Trust II-JPMorg… | 0.54% | 1.17 Mln | 2026-06-30 |
| iShares Trust-iShares Ru… | 0.51% | 1.1 Mln | 2026-07-31 |
| GOLDSMITH MARK A (Chief… | ≈0.46% | 984 238 | 2026-08-21 |
| KELSEY STEPHEN MICHAEL (… | ≈0.14% | 291 876 | 2026-09-11 |
| HORN MARGARET A (Chief O… | ≈0.07% | 154 647 | 2026-06-17 |
| ANDERS JACK LEE (Chief F… | ≈0.06% | 123 269 | 2026-06-24 |
| WANG XIAOLIN (Officer) | ≈0.05% | 116 063 | 2026-03-17 |
| LIN WEI (Officer) | ≈0.05% | 101 366 | 2026-03-17 |
| HORNING SANDRA (Director… | ≈0.05% | 97 765 | 2026-06-18 |
| CISLINI JEFFREY TODD (Ge… | ≈0.03% | 55 907 | 2026-08-21 |
| SCHROEDER THILO (Directo… | — | — | 2024-12-05 |
